Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

被引：0
|
作者：
Anne Bertrand
Marie Kostine
Thomas Barnetche
Marie-Elise Truchetet
Thierry Schaeverbeke
机构：
[1] Département de Rhumatologie,Laboratoire d’Immunologie, UMR
[2] Hôpital Pellegrin,CNRS 5164
[3] CHU de Bordeaux,Unité sous Contrat, Infections à Mycoplasmes et à Chlamydia chez l’Homme
[4] Université de Bordeaux,undefined
[5] Université de Bordeaux,undefined
来源：
BMC Medicine | / 13卷
关键词：
Anti-CTLA4 antibodies; Colitis; Dermatitis; Hypohysitis; Immune related adverse events; Ipilimumab; Metastatic tumors; Oncology; Tremelimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    Bertrand, Anne
    Kostine, Marie
    Barnetche, Thomas
    Truchetet, Marie-Elise
    Schaeverbeke, Thierry
    BMC MEDICINE, 2015, 13
  • [2] Review: Anti-CTLA-4 antibody ipilimumab: Case studies of clinical response and immune-related adverse events
    Weber, Jeffrey
    ONCOLOGIST, 2007, 12 (07) : 864 - 872
  • [3] Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy
    Bronstein, Yulia
    Ng, Chaan S.
    Hwu, Patrick
    Hwu, Wen-Jen
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (06) : W992 - W1000
  • [4] Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysis
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [5] Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities
    Coutzac, Clelia
    Adam, Julien
    Soularue, Emilie
    Collins, Michael
    Racine, Antoine
    Mussini, Charlotte
    Boselli, Lisa
    Kamsukom, Nyam
    Mateus, Christine
    Charrier, Melinda
    Cassard, Lydie
    Planchard, David
    Ribrag, Vincent
    Fizazi, Karim
    Loriot, Yohann
    Lepage, Patricia
    Scoazec, Jean-Yves
    Robert, Caroline
    Carbonnel, Franck
    Chaput, Nathalie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10) : 1238 - 1246
  • [6] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Zhou, Xiaoxiang
    Yao, Zhuoran
    Yang, Huaxia
    Liang, Naixin
    Zhang, Xuan
    Zhang, Fengchun
    BMC MEDICINE, 2020, 18 (01)
  • [7] Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials
    Yun, Seongseok
    Vincelette, Nicole D.
    Green, Myke R.
    Hendrickson, Andrea E. Wahner
    Abraham, Ivo
    CANCER MEDICINE, 2016, 5 (07): : 1481 - 1491
  • [8] Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis
    Xu, Hang
    Tan, Ping
    Zheng, Xiaonan
    Huang, Yu
    Lin, Tianhai
    Wei, Qiang
    Ai, Jianzhong
    Yang, Lu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2215 - 2234
  • [9] Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
    Dillard, Troy
    Yedinak, Chris G.
    Alumkal, Joshi
    Fleseriu, Maria
    PITUITARY, 2010, 13 (01) : 29 - 38
  • [10] Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials
    Zhang, Leyin
    Sun, Leitao
    Zhou, Yiwen
    Yu, Jieru
    Lin, Yingying
    Wasan, Harpreet S.
    Shen, Minhe
    Ruan, Shanming
    FRONTIERS IN ONCOLOGY, 2021, 11
12345